Envisia Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma (NCT02371746) | Envisia Therapeutics | 2015-01-01 |
Track Envisia Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.